Pulmonary resection for Mycobacterium xenopi pulmonary infection

Annals of Thoracic Surgery

Volumn 72, Issue 6, 2001, Pages 1877-1882

  Lang Lazdunski, Loïc ^b   Offredo, Catherine ^b   Le Pimpec Barthes, Françoise ^b   Danel, Claire ^b   Dujon, Antoine ^b   Riquet, Marc ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN;

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; FOLLOW UP; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; LUNG INFECTION; LUNG LOBECTOMY; LUNG RESECTION; MALE; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAPSE; SPUTUM CULTURE; SPUTUM SMEAR; SYMPTOM; THORAX DRAINAGE; TREATMENT INDICATION;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HUMANS; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI; PNEUMONECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUBERCULOSIS, PULMONARY;

EID: 0035668165     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03245-3     Document Type: Article

References (26)

1. American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria
2. Mycobacterium xenopi lung infection in HIV-negative patients: A propos of 8 cases
3. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS: Clarithromycin Study Group of France
4. The use of rifabutin in Europe for the treatment of mycobacterial infection in AIDS patients
5. Pulmonary infection with Mycobacterium xenopi: Review of treatment and response
6. Pulmonary mycobacteriosis due to Mycobacterium xenopi: In-vitro sensitivity to classical antitubercular agents and clinical development
7. Radiometric susceptibility testing of Mycobacterium xenopi
8. An infection by Mycobacterium xenopi in bullous emphysema: A report of four operated cases
9. Long-term results of pulmonary resection for atypical mycobacterial disease
10. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections
11. Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection
12. A strain of mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli
13. Infection due to Mycobacterium xenopi
14. Increasing incidence of Mycobacterium xenopi at Bellevue Hospital. An emerging pathogen or a product of improved laboratory methods?
15. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients
16. Mycobacterium xenopi infection in patients with human immunodeficiency virus infection
17. Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi
18. First randomized trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense, and M. xenopi in HIV negative patients: Rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
19. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin
20. Mycobacterium xenopi pulmonary infection: Evaluation with CT
21. Mycobacterium xenopi infection and aspergilloma
22. Lung cancer occuring with Mycobacterium xenopi and Aspergillus
23. Surgical management of pulmonary tuberculosis due to atypical mycobacteria
24. Early pulmonary resection for localized Mycobacterium xenopi complex disease
25. Surgical treatment of atypical pulmonary tuberculosis
26. Preliminary results of collapse therapy with plombage for pulmonary disease caused by multidrug-resistant mycobacteria